Moleculin Reports Second Quarter 2025 Financial Results and Highlights
Go back to Moleculin Reports Second Quarter 2025 Financial Results and Highlights| METABASIS THERAPEUT (NASDAQ: MBRX) | Delayed: 0.60 +0.01 (1.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.59 | 52 Week High | $9.58 | |||
| Open | $0.59 | 52 Week Low | $2.34 | |||
| Day High | $0.63 | P/E | N/A | |||
| Day Low | $0.59 | EPS | $-0.34 | |||
| Volume | 45,603 | |||||
